Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

HILLS & DALES GENERAL HOSPITAL, INC.

NPI: 1487924221 · CASS CITY, MI 48726 · Rural Health Clinic/Center · NPI assigned 01/11/2012

$839K
Total Medicaid Paid
88,952
Total Claims
81,891
Beneficiaries
47
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGENTNER, KIMBERLY (CHIEF FINANCIAL OFFICER)
NPI Enumeration Date01/11/2012

Related Entities

Other providers sharing the same authorized official: GENTNER, KIMBERLY

ProviderCityStateTotal Paid
DECKERVILLE COMMUNITY HOSPITAL, INC. DECKERVILLE MI $1.49M
DECKERVILLE COMMUNITY HOSPITAL, INC DECKERVILLE MI $880K
HILLS & DALES GENERAL HOSPITAL, INC. CARO MI $362K
DECKERVILLE COMMUNITY HOSPITAL, INC. DECKERVILLE MI $246K
HILLS & DALES GENERAL HOSPITAL, INC. CARO MI $115K
DECKERVILLE COMMUNITY HOSPITAL, INC. DECKERVILLE MI $22K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 11,025 $96K
2019 12,349 $122K
2020 10,891 $107K
2021 16,340 $160K
2022 19,538 $179K
2023 14,332 $128K
2024 4,477 $46K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
T1015 Clinic visit/encounter, all-inclusive 13,993 12,440 $692K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 5,257 4,895 $65K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 6,425 6,101 $63K
99000 946 922 $8K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 799 391 $3K
87428 530 524 $2K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 65 65 $1K
90686 123 122 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 995 970 $849.46
87807 261 257 $822.15
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 51 51 $576.47
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 308 288 $486.98
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 280 273 $466.08
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 27 26 $387.48
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 41 40 $382.32
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 145 144 $332.72
96160 39 39 $200.00
36415 Collection of venous blood by venipuncture 161 156 $164.67
96127 36 35 $25.53
81002 52 49 $17.28
3075F 1,771 1,703 $0.00
1034F 2,426 2,204 $0.00
2010F 9,720 8,905 $0.00
3074F 7,203 6,758 $0.00
3079F 2,791 2,652 $0.00
3017F 674 597 $0.00
2000F 8,498 7,822 $0.00
3044F 119 105 $0.00
1220F 363 359 $0.00
1036F 6,197 5,728 $0.00
3048F 271 249 $0.00
1125F 53 52 $0.00
0529F 126 116 $0.00
3014F 32 25 $0.00
3080F 114 112 $0.00
4037F 17 17 $0.00
1000F 13 12 $0.00
3049F 16 15 $0.00
1159F 10,723 9,788 $0.00
3078F 6,548 6,174 $0.00
G8482 Influenza immunization administered or previously received 30 30 $0.00
3077F 572 544 $0.00
1033F 27 26 $0.00
3050F 27 25 $0.00
G8483 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) 50 48 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 25 25 $0.00
1090F 12 12 $0.00